Nitroplast

Nitroplast

Classification
External resources

{{This medical treatment related article is a stub. You can help WikiMD by expanding it.}}

Nitroplast is a medical device used in the treatment of cardiovascular disease, specifically for the management of coronary artery disease. It is a type of stent that is coated with a nitroglycerin-based compound, designed to provide both mechanical support to the artery and pharmacological benefits to prevent restenosis.

Mechanism of Action

Nitroplast stents work by combining the mechanical properties of traditional stents with the vasodilatory effects of nitroglycerin. The stent is deployed in the narrowed section of a coronary artery, where it acts as a scaffold to keep the artery open. The nitroglycerin coating is gradually released, which helps to dilate the blood vessel and improve blood flow. This dual action helps to reduce the risk of restenosis, a common complication where the artery narrows again after stent placement.

Clinical Applications

Nitroplast is primarily used in patients with angina pectoris and those who have experienced a myocardial infarction. It is particularly beneficial in cases where there is a high risk of restenosis or in patients with small vessel disease. The use of Nitroplast can lead to improved outcomes by reducing the need for repeat revascularization procedures.

Advantages

• Reduced Restenosis Rates: The nitroglycerin coating helps to prevent the proliferation of smooth muscle cells, which is a key factor in restenosis.
• Improved Blood Flow: The vasodilatory effect of nitroglycerin enhances blood flow through the treated artery.
• Dual Action: Combines mechanical support with pharmacological therapy.

Risks and Considerations

While Nitroplast offers several benefits, there are potential risks associated with its use:

• Allergic Reactions: Some patients may have an allergic reaction to nitroglycerin or the materials used in the stent.
• Bleeding: As with any stent, there is a risk of bleeding, particularly if the patient is on antiplatelet therapy.
• Stent Thrombosis: Although rare, there is a risk of stent thrombosis, which can lead to a heart attack.

Research and Development

Ongoing research is focused on improving the drug-eluting properties of Nitroplast and exploring its use in other vascular territories. Studies are also examining the long-term outcomes of patients treated with Nitroplast compared to other types of stents.

Also see

• Coronary artery disease
• Stent
• Nitroglycerin
• Angioplasty
• Drug-eluting stent

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy